Systematic review and meta-analysis of the risk of severe and life-threatening thromboembolism in cancer patients receiving anti-EGFR monoclonal antibodies (cetuximab or panitumumab)-Reference-Cited by-同舟云学术

Systematic review and meta-analysis of the risk of severe and life-threatening thromboembolism in cancer patients receiving anti-EGFR monoclonal antibodies (cetuximab or panitumumab)

Published:2016-07-28 Issue:10 Volume:139 Page:2370-2380
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Miroddi Marco¹²,Sterrantino Carmelo²³,Simmonds Mark¹,Caridi Luigi³,Calapai Gioacchino¹,Phillips Robert S.²⁴,Stewart Lesley A.²

Affiliation:

1. Department of Biomedical and Dental Sciences and Morphofunctional Imaging; University of Messina; Messina Italy

2. Centre for Reviews and Dissemination; University of York; York United Kingdom

3. Department of Clinical and Experimental Medicine; University of Messina; Messina Italy

4. Department of Paediatric Oncology Haematology; Leeds General Infirmary; Leeds United Kingdom

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference61 articles.

1. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer;Akl;Cochrane Database Syst Rev,2014

2. Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management;Donnellan;Curr Oncol,2014

3. Cancer-associated thrombosis: an overview;Elyamany;Clin Med Insights Oncol,2014

4. Epidemiology of cancer-associated venous thrombosis;Timp;Blood,2013

5. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis;Horsted;PLoS Med,2012

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors analysis of lung cancer combined with venous thromboembolism and the construction of a clinic prediction model;2024-09-03

2. Antibodies and complement are key drivers of thrombosis;Immunity;2024-09

3. The Role of the PI3K/Akt/mTOR Axis in Head and Neck Squamous Cell Carcinoma;Biomedicines;2024-07-19

4. The state of the art in secondary pharmacology and its impact on the safety of new medicines;Nature Reviews Drug Discovery;2024-05-21

5. Oncogenes and cancer associated thrombosis: what can we learn from single cell genomics about risks and mechanisms?;Frontiers in Medicine;2023-12-20